drugset / Trial / NCT05364177

68Ga-pentixather and 68Ga-pentixafor PET/CT in Multiple Myeloma

NCT05364177

Phase 0 Unknown 100 enrolled Peking Union Medical College Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

Chemokine receptor-4 (CXCR4) is overexpressed in multiple myeloma (MM) cells. 68Ga-pentixafor is a radio-labled tracer for CXCR4 . 68Ga-pentixafor PET/CT has shown good diagnostic performance in MM. But an exchange of Ga3+ by Lu3+ or Y3+ will lead to a significant loss of CXCR4 affinity. Investigators conduct this prospective study to evaluate the diagnostic performance of 68Ga-pentixather compared with 68Ga-pentixafor, in order to parallel 68Ga-pentixather and 177Lu/90Y-pentixather in theranostics of MM.

Timeline

Start
2021-08-11
Primary completion
2024-08
Completion
2024-08

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-Pentixafor Peptide Intravenous
Subject 68Ga-Pentixather Diagnostic / imaging agent Intravenous

Indications